Cart
sales@molnova.com
SAR348830
CAS No. 1462949-64-9
SAR348830( —— )
Catalog No. M20540 CAS No. 1462949-64-9
SAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 53 | In Stock |
|
| 25MG | 87 | In Stock |
|
| 50MG | 145 | In Stock |
|
| 100MG | 221 | In Stock |
|
| 200MG | 332 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSAR348830
-
NoteResearch use only, not for human use.
-
Brief DescriptionSAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
-
DescriptionSAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1462949-64-9
-
Formula Weight537.7
-
Molecular FormulaC28H32FN5O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (185.99 mM)
-
SMILESCOc1ccc(F)cc1-c1c(CO)sc2cnc(Nc3ccc(cc3OC(C)C)N3CCN(C)CC3)nc12
-
Chemical Name7-(5-Fluoro-2-methoxyphenyl)-2-[[2-(1-methylethoxy)-4-(4-methyl-1-piperazinyl)phenyl]amino]-thieno[32-d]pyrimidine-6-methanol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4-Methylsalicylic ac...
4-Methylsalicylic acid is used to inhibit the medium chain acyl-CoA synthetase.
-
Cyclo(L-Pro-L-Val)
Cyclo(L-Pro-L-Val), a 2,5-diketopiperazine extracted from the fruits of Mycobacterium chiliolyticum AZ2 and Mycobacterium leprae, possesses anti-inflammatory activity and virulence activity against phytopathogenic microorganisms (e.g., R. fascians LMG 3605) and inhibits Gram-positive plant pathogens.
-
(-)-Epiafzelechin
(-)-Epiafzelechin exhibits significant anti-inflammatory activity on carrageenin-induced mouse paw edema, it exhibits a dose-dependent inhibition on the COX activity with an IC50 value of 15 microM, it exhibits about 3-fold weaker inhibitory potency on the enzyme activity than indomethacin as a positive control.
